Biomedical subjects

Aixi Yu

Publications and source records attributed to Aixi Yu.

2 recordsLinked to original sources

PubMed2006

Biodegradable polylactide/chitosan blend membranes.

Biodegradable blend membranes based on polylactide and chitosan with various compositions were prepared via a two-step processing pathway. In the first step, solutions of each component were properly mixed and cast into a gelatinous membrane, and in the second step, the obtained membrane was immersed into a mixed solution for the solvent extraction followed by a drying procedure to finally generate a well-blended membrane. An acetic acid-acetone solvent system was selected for poly(DL-lactide)/chitosan membranes, and another solvent system for poly(L-lactide)/chitosan membranes consisted of acetic acid and dimethyl sulfoxide. Some processing parameters, such as the concentration of component solutions and the composition ratio of mixed solvents and extraction solvents, were optimized by primarily considering whether the directly visible phase separation occurred during the processing procedures. Morphologies of these blend membranes were viewed using SEM. It was found that the processing parameters exerted quite notable impacts on the morphology of the membranes. The hydrophilicity of membranes was examined by measuring their water contact angle and swelling index. These blend membranes were also investigated for their miscibility using IR spectra, X-ray diffractograms, TG, DSC, and dynamic mechanical analysis methods. Although the presence of phase separation at a microscopic level was detected for these membranes, pronounced interactions between components were confirmed. The obtained results shown that some membranes prepared under optimized processing conditions had a partially miscible structure.

Acetic Acid↗

PubMed2005

Porous-conductive chitosan scaffolds for tissue engineering II. in vitro and in vivo degradation.

Porous-conductive chitosan scaffolds were fabricated by blending conductive polypyrrole (PPy) particles with chitosan solution and employing an improved phase separation method. In vitro and in vivo degradation behaviors of these scaffolds were investigated. In the case of in vitro degradation, an enzymatic degradation system was employed and lysozyme was used as a working enzyme. Meanwhile, the degradation products of scaffolds, glucosamine and N-acetyl-glucosamine, were also analyzed with a HPLC method. In vivo degradation of scaffolds was performed by subcutaneously implanting these scaffolds in rat for pre-scheduled time intervals. In the both cases, the weight-loss of scaffolds was monitored during the whole degradation process for evaluating the degradation of scaffolds. The changes in conductivity of scaffolds afterin vitro or in vivo degradation were also measured using a four-point technique. It was observed that the pore parameters of scaffolds themselves could significantly influence the degradation behaviors of scaffolds but the PPy content in the scaffolds seemed not to impart its effect to the degradation of scaffolds. Degradation dynamics of scaffolds and conductivity measurements indicated that these scaffolds shown fairly different behaviors in their in vitro and in vivo degradation process. According to the results obtained from in vitro and in vivo degradation of scaffolds and based on some requirements of practical tissue engineering application, it was suggested that the PPy content in the scaffold should be slightly higher than 3 wt.% but lower than 6 wt.%.

Animals↗